Sector Chart Synlogic, Inc.

Stocks

SYBX

US87166L2097

Biotechnology & Medical Research

Market Closed - OTC Markets 18:47:03 02/06/2026 +04			5-day change	1st Jan Change
0.7000 ^USD	+1.45%		-36.36%	-37.50%

08-12	Synlogic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	Caldera Therapeutics, Inc. entered into an agreement and plan of merger to acquire Synlogic, Inc. for an enterprise value of approximately $500 million in a reverse merger transaction.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes